{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:35:31Z","timestamp":1790768131415,"version":"4.1.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR000135"],"award-info":[{"award-number":["UL1 TR000135"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P50 AG 16574"],"award-info":[{"award-number":["P50 AG 16574"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Quark Pharmaceuticals","award":["QRK207"],"award-info":[{"award-number":["QRK207"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00415-018-9051-0","type":"journal-article","created":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T05:09:16Z","timestamp":1536728956000},"page":"2103-2111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Early ophthalmologic features of Parkinson\u2019s disease: a review of preceding clinical and diagnostic markers"],"prefix":"10.1007","volume":"266","author":[{"given":"Pierpaolo","family":"Turcano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta L.","family":"Bureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2543-0627","authenticated-orcid":false,"given":"Rodolfo","family":"Savica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,12]]},"reference":[{"key":"9051_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archneur.56.1.33","volume":"56","author":"DJ Gelb","year":"1999","unstructured":"Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33\u201339","journal-title":"Arch Neurol"},{"key":"9051_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3109\/17482968.2012.724075","volume":"14","author":"EA Coon","year":"2013","unstructured":"Coon EA, Daube JR, Dejesus-Hernandez M, Adeli A, Savica R, Parisi JE, Dickson DW, Josephs KA, Baker MC, Johnson KA, Ivnik RJ, Petersen RC, Knopman DS, Boylan KB, Rademakers R, Boeve BF (2013) Clinical and electrophysiologic variability in amyotrophic lateral sclerosis within a kindred harboring the C9ORF72 repeat expansion. Amyotrophic Lateral Scler Frontotemporal Degener 14:132\u2013137. \n                    https:\/\/doi.org\/10.3109\/17482968.2012.724075","journal-title":"Amyotrophic Lateral Scler Frontotemporal Degener"},{"key":"9051_CR3","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S1474-4422(06)70476-8","volume":"5","author":"A Iranzo","year":"2006","unstructured":"Iranzo A, Molinuevo JL, Santamaria J, Serradell M, Marti MJ, Valldeoriola F, Tolosa E (2006) Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 5:572\u2013577","journal-title":"Lancet Neurol"},{"key":"9051_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1474-4422(13)70056-5","volume":"12","author":"A Iranzo","year":"2013","unstructured":"Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M, Sanchez-Valle R, Vilaseca I, Lomena F, Vilas D, Llado A, Gaig C, Santamaria J (2013) Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol 12:443\u2013453. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(13)70056-5","journal-title":"Lancet Neurol"},{"key":"9051_CR5","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1212\/WNL.0b013e3181c34af5","volume":"73","author":"R Savica","year":"2009","unstructured":"Savica R, Carlin JM, Grossardt BR, Bower JH, Ahlskog JE, Maraganore DM, Bharucha AE, Rocca WA (2009) Medical records documentation of constipation preceding Parkinson disease: a case-control study. Neurology 73:1752\u20131758. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3181c34af5","journal-title":"Neurology"},{"key":"9051_CR6","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/ana.22282","volume":"69","author":"RB Postuma","year":"2011","unstructured":"Postuma RB, Gagnon JF, Vendette M, Desjardins C, Montplaisir JY (2011) Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol 69:811\u2013818. \n                    https:\/\/doi.org\/10.1002\/ana.22282","journal-title":"Ann Neurol"},{"key":"9051_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5","volume":"15","author":"M Shiba","year":"2000","unstructured":"Shiba M, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA (2000) Anxiety disorders and depressive disorders preceding Parkinson\u2019s disease: a case-control study. Mov Disord 15:669\u2013677","journal-title":"Mov Disord"},{"key":"9051_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"9051_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/CCID.S130319","volume":"10","author":"AH Ravn","year":"2017","unstructured":"Ravn AH, Thyssen JP, Egeberg A (2017) Skin disorders in Parkinson\u2019s disease: potential biomarkers and risk factors. Clin Cosmet Investig Dermatol 10:87\u201392. \n                    https:\/\/doi.org\/10.2147\/CCID.S130319","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"9051_CR10","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/ene.13290","volume":"24","author":"M Picillo","year":"2017","unstructured":"Picillo M, Palladino R, Barone P, Erro R, Colosimo C, Marconi R, Morgante L, Antonini A, Group PS (2017) The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson\u2019s disease. Eur J Neurol 24:788\u2013795. \n                    https:\/\/doi.org\/10.1111\/ene.13290","journal-title":"Eur J Neurol"},{"key":"9051_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00702-017-1676-0","volume":"124","author":"L Brabenec","year":"2017","unstructured":"Brabenec L, Mekyska J, Galaz Z, Rektorova I (2017) Speech disorders in Parkinson\u2019s disease: early diagnostics and effects of medication and brain stimulation. J Neural Transm 124:303\u2013334. \n                    https:\/\/doi.org\/10.1007\/s00702-017-1676-0","journal-title":"J Neural Transm"},{"key":"9051_CR12","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/mds.22963","volume":"25","author":"NJ Diederich","year":"2010","unstructured":"Diederich NJ, Pieri V, Hipp G, Rufra O, Blyth S, Vaillant M (2010) Discriminative power of different nonmotor signs in early Parkinson\u2019s disease. A case-control study. Mov Disord 25:882\u2013887. \n                    https:\/\/doi.org\/10.1002\/mds.22963","journal-title":"Mov Disord"},{"key":"9051_CR13","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.visres.2004.11.006","volume":"45","author":"S Davidsdottir","year":"2005","unstructured":"Davidsdottir S, Cronin-Golomb A, Lee A (2005) Visual and spatial symptoms in Parkinson\u2019s disease. Vision Res 45:1285\u20131296. \n                    https:\/\/doi.org\/10.1016\/j.visres.2004.11.006","journal-title":"Vision Res"},{"key":"9051_CR14","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.parkreldis.2013.12.009","volume":"20","author":"P Urwyler","year":"2014","unstructured":"Urwyler P, Nef T, Killen A, Collerton D, Thomas A, Burn D, McKeith I, Mosimann UP (2014) Visual complaints and visual hallucinations in Parkinson\u2019s disease. Parkinsonism Relat Disord 20:318\u2013322. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2013.12.009","journal-title":"Parkinsonism Relat Disord"},{"key":"9051_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/01.WNL.0000103444.45882.D8","volume":"62","author":"V Biousse","year":"2004","unstructured":"Biousse V, Skibell BC, Watts RL, Loupe DN, Drews-Botsch C, Newman NJ (2004) Ophthalmologic features of Parkinson\u2019s disease. Neurology 62:177\u2013180","journal-title":"Neurology"},{"key":"9051_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/cne.902100108","volume":"210","author":"JM Frederick","year":"1982","unstructured":"Frederick JM, Rayborn ME, Laties AM, Lam DM, Hollyfield JG (1982) Dopaminergic neurons in the human retina. J Comp Neurol 210:65\u201379. \n                    https:\/\/doi.org\/10.1002\/cne.902100108","journal-title":"J Comp Neurol"},{"key":"9051_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/BF02307822","volume":"10","author":"J Nguyen-Legros","year":"1988","unstructured":"Nguyen-Legros J (1988) Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson\u2019s disease. Surg Radiol Anat 10:137\u2013144","journal-title":"Surg Radiol Anat"},{"key":"9051_CR18","first-page":"2473","volume":"31","author":"C Harnois","year":"1990","unstructured":"Harnois C, Di Paolo T (1990) Decreased dopamine in the retinas of patients with Parkinson\u2019s disease. Invest Ophthalmol Vis Sci 31:2473\u20132475","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9051_CR19","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/ana.24182","volume":"75","author":"I Bodis-Wollner","year":"2014","unstructured":"Bodis-Wollner I, Kozlowski PB, Glazman S, Miri S (2014) \u03b1-Synuclein in the inner retina in parkinson disease. Ann Neurol 75:964\u2013966. \n                    https:\/\/doi.org\/10.1002\/ana.24182","journal-title":"Ann Neurol"},{"key":"9051_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neulet.2014.04.027","volume":"571","author":"TG Beach","year":"2014","unstructured":"Beach TG, Carew J, Serrano G, Adler CH, Shill HA, Sue LI, Sabbagh MN, Akiyama H, Cuenca N, Arizona Parkinson\u2019s Disease C (2014) Phosphorylated alpha-synuclein-immunoreactive retinal neuronal elements in Parkinson\u2019s disease subjects. Neurosci Lett 571:34\u201338. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2014.04.027","journal-title":"Neurosci Lett"},{"key":"9051_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/WNR.0b013e32835edbc5","volume":"24","author":"SB Koh","year":"2013","unstructured":"Koh SB, Suh SI, Kim SH, Kim JH (2013) Stereopsis and extrastriate cortical atrophy in Parkinson\u2019s disease: a voxel-based morphometric study. Neuroreport 24:229\u2013232. \n                    https:\/\/doi.org\/10.1097\/WNR.0b013e32835edbc5","journal-title":"Neuroreport"},{"key":"9051_CR22","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1212\/01.WNL.0000141853.27081.BD","volume":"63","author":"GT Stebbins","year":"2004","unstructured":"Stebbins GT, Goetz CG, Carrillo MC, Bangen KJ, Turner DA, Glover GH, Gabrieli JD (2004) Altered cortical visual processing in PD with hallucinations: an fMRI study. Neurology 63:1409\u20131416","journal-title":"Neurology"},{"key":"9051_CR23","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1148\/radiol.2017161732","volume":"285","author":"A Arrigo","year":"2017","unstructured":"Arrigo A, Calamuneri A, Milardi D, Mormina E, Rania L, Postorino E, Marino S, Di Lorenzo G, Anastasi GP, Ghilardi MF, Aragona P, Quartarone A, Gaeta M (2017) Visual system involvement in patients with newly diagnosed Parkinson disease. Radiology 285:885\u2013895. \n                    https:\/\/doi.org\/10.1148\/radiol.2017161732","journal-title":"Radiology"},{"key":"9051_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.bandc.2008.08.015","volume":"68","author":"JA Sharpe","year":"2008","unstructured":"Sharpe JA (2008) Neurophysiology and neuroanatomy of smooth pursuit: lesion studies. Brain Cogn 68:241\u2013254. \n                    https:\/\/doi.org\/10.1016\/j.bandc.2008.08.015","journal-title":"Brain Cogn"},{"key":"9051_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00019052-200402000-00005","volume":"17","author":"C Pierrot-Deseilligny","year":"2004","unstructured":"Pierrot-Deseilligny C, Milea D, Muri RM (2004) Eye movement control by the cerebral cortex. Curr Opin Neurol 17:17\u201325","journal-title":"Curr Opin Neurol"},{"key":"9051_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/155005940803900404","volume":"39","author":"JW Rieger","year":"2008","unstructured":"Rieger JW, Kim A, Argyelan M, Farber M, Glazman S, Liebeskind M, Meyer T, Bodis-Wollner I (2008) Cortical functional anatomy of voluntary saccades in Parkinson disease. Clin EEG Neurosci 39:169\u2013174. \n                    https:\/\/doi.org\/10.1177\/155005940803900404","journal-title":"Clin EEG Neurosci"},{"key":"9051_CR27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/mds.24996","volume":"27","author":"RB Postuma","year":"2012","unstructured":"Postuma RB, Aarsland D, Barone P, Burn DJ, Hawkes CH, Oertel W, Ziemssen T (2012) Identifying prodromal Parkinson\u2019s disease: pre-motor disorders in Parkinson\u2019s disease. Mov Disord 27:617\u2013626. \n                    https:\/\/doi.org\/10.1002\/mds.24996","journal-title":"Mov Disord"},{"key":"9051_CR28","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1016\/j.visres.2004.06.009","volume":"44","author":"R Inzelberg","year":"2004","unstructured":"Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A (2004) Retinal nerve fiber layer thinning in Parkinson disease. Vision Res 44:2793\u20132797. \n                    https:\/\/doi.org\/10.1016\/j.visres.2004.06.009","journal-title":"Vision Res"},{"key":"9051_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10633-007-9091-8","volume":"116","author":"O Altintas","year":"2008","unstructured":"Altintas O, Iseri P, Ozkan B, Caglar Y (2008) Correlation between retinal morphological and functional findings and clinical severity in Parkinson\u2019s disease. Doc Ophthalmol 116:137\u2013146. \n                    https:\/\/doi.org\/10.1007\/s10633-007-9091-8","journal-title":"Doc Ophthalmol"},{"key":"9051_CR30","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1468-1331.2012.03701.x","volume":"20","author":"C La Morgia","year":"2013","unstructured":"La Morgia C, Barboni P, Rizzo G, Carbonelli M, Savini G, Scaglione C, Capellari S, Bonazza S, Giannoccaro MP, Calandra-Buonaura G, Liguori R, Cortelli P, Martinelli P, Baruzzi A, Carelli V (2013) Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? Eur J Neurol 20:198\u2013201. \n                    https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03701.x","journal-title":"Eur J Neurol"},{"key":"9051_CR31","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/mds.25896","volume":"29","author":"NM Roth","year":"2014","unstructured":"Roth NM, Saidha S, Zimmermann H, Brandt AU, Isensee J, Benkhellouf-Rutkowska A, Dornauer M, Kuhn AA, Muller T, Calabresi PA, Paul F (2014) Photoreceptor layer thinning in idiopathic Parkinson\u2019s disease. Mov Disord 29:1163\u20131170. \n                    https:\/\/doi.org\/10.1002\/mds.25896","journal-title":"Mov Disord"},{"key":"9051_CR32","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1002\/mds.23891","volume":"26","author":"NK Archibald","year":"2011","unstructured":"Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2011) Visual symptoms in Parkinson\u2019s disease and Parkinson\u2019s disease dementia. Mov Disord 26:2387\u20132395. \n                    https:\/\/doi.org\/10.1002\/mds.23891","journal-title":"Mov Disord"},{"key":"9051_CR33","doi-asserted-by":"publisher","first-page":"8503859","DOI":"10.1155\/2016\/8503859","volume":"2016","author":"M Satue","year":"2016","unstructured":"Satue M, Obis J, Rodrigo MJ, Otin S, Fuertes MI, Vilades E, Gracia H, Ara JR, Alarcia R, Polo V, Larrosa JM, Pablo LE, Garcia-Martin E (2016) Optical coherence tomography as a biomarker for diagnosis, progression, and prognosis of neurodegenerative diseases. J Ophthalmol 2016:8503859. \n                    https:\/\/doi.org\/10.1155\/2016\/8503859","journal-title":"J Ophthalmol"},{"key":"9051_CR34","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ajo.2013.09.028","volume":"157","author":"E Garcia-Martin","year":"2014","unstructured":"Garcia-Martin E, Larrosa JM, Polo V, Satue M, Marques ML, Alarcia R, Seral M, Fuertes I, Otin S, Pablo LE (2014) Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration. Am J Ophthalmol 157:470\u2013478 e472. \n                    https:\/\/doi.org\/10.1016\/j.ajo.2013.09.028","journal-title":"Am J Ophthalmol"},{"key":"9051_CR35","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1097\/IAE.0000000000000028","volume":"34","author":"E Garcia-Martin","year":"2014","unstructured":"Garcia-Martin E, Satue M, Otin S, Fuertes I, Alarcia R, Larrosa JM, Polo V, Pablo LE (2014) Retina measurements for diagnosis of Parkinson disease. Retina 34:971\u2013980. \n                    https:\/\/doi.org\/10.1097\/IAE.0000000000000028","journal-title":"Retina"},{"key":"9051_CR36","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1136\/bjophthalmol-2013-304152","volume":"98","author":"M Satue","year":"2014","unstructured":"Satue M, Seral M, Otin S, Alarcia R, Herrero R, Bambo MP, Fuertes MI, Pablo LE, Garcia-Martin E (2014) Retinal thinning and correlation with functional disability in patients with Parkinson\u2019s disease. Br J Ophthalmol 98:350\u2013355. \n                    https:\/\/doi.org\/10.1136\/bjophthalmol-2013-304152","journal-title":"Br J Ophthalmol"},{"key":"9051_CR37","doi-asserted-by":"publisher","first-page":"e0177163","DOI":"10.1371\/journal.pone.0177163","volume":"12","author":"E Garcia-Martin","year":"2017","unstructured":"Garcia-Martin E, Pablo LE, Bambo MP, Alarcia R, Polo V, Larrosa JM, Vilades E, Cameo B, Orduna E, Ramirez T, Satue M (2017) Comparison of peripapillary choroidal thickness between healthy subjects and patients with Parkinson\u2019s disease. PLoS One 12:e0177163. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0177163","journal-title":"PLoS One"},{"key":"9051_CR38","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1212\/WNL.45.2.386","volume":"45","author":"T Buttner","year":"1995","unstructured":"Buttner T, Kuhn W, Muller T, Patzold T, Heidbrink K, Przuntek H (1995) Distorted color discrimination in \u2018de novo\u2019 parkinsonian patients. Neurology 45:386\u2013387","journal-title":"Neurology"},{"key":"9051_CR39","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/mds.25272","volume":"27","author":"JA Bertrand","year":"2012","unstructured":"Bertrand JA, Bedetti C, Postuma RB, Monchi O, Genier Marchand D, Jubault T, Gagnon JF (2012) Color discrimination deficits in Parkinson\u2019s disease are related to cognitive impairment and white-matter alterations. Mov Disord 27:1781\u20131788. \n                    https:\/\/doi.org\/10.1002\/mds.25272","journal-title":"Mov Disord"},{"key":"9051_CR40","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1016\/S0042-6989(97)00402-1","volume":"38","author":"BC Regan","year":"1998","unstructured":"Regan BC, Freudenthaler N, Kolle R, Mollon JD, Paulus W (1998) Colour discrimination thresholds in Parkinson\u2019s disease: results obtained with a rapid computer-controlled colour vision test. Vision Res 38:3427\u20133431","journal-title":"Vision Res"},{"key":"9051_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0022-510X(03)00150-3","volume":"213","author":"T Muller","year":"2003","unstructured":"Muller T, Meisel M, Russ H, Przuntek H (2003) Motor impairment influences Farnsworth\u2013Munsell 100 Hue test error scores in Parkinson\u2019s disease patients. J Neurol Sci 213:61\u201365","journal-title":"J Neurol Sci"},{"key":"9051_CR42","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1093\/brain\/awh581","volume":"128","author":"MF Silva","year":"2005","unstructured":"Silva MF, Faria P, Regateiro FS, Forjaz V, Januario C, Freire A, Castelo-Branco M (2005) Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson\u2019s disease. Brain 128:2260\u20132271. \n                    https:\/\/doi.org\/10.1093\/brain\/awh581","journal-title":"Brain"},{"key":"9051_CR43","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3233\/JPD-140359","volume":"4","author":"A Piro","year":"2014","unstructured":"Piro A, Tagarelli A, Nicoletti G, Fletcher R, Quattrone A (2014) Color vision impairment in Parkinson\u2019s disease. J Parkinsons Dis 4:317\u2013319. \n                    https:\/\/doi.org\/10.3233\/JPD-140359","journal-title":"J Parkinsons Dis"},{"issue":"Pt 3","key":"9051_CR44","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/brain\/118.3.771","volume":"118","author":"BA Haug","year":"1995","unstructured":"Haug BA, Kolle RU, Trenkwalder C, Oertel WH, Paulus W (1995) Predominant affection of the blue cone pathway in Parkinson\u2019s disease. Brain 118(Pt 3):771\u2013778","journal-title":"Brain"},{"key":"9051_CR45","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1212\/01.wnl.0000203648.80727.5b","volume":"66","author":"RB Postuma","year":"2006","unstructured":"Postuma RB, Lang AE, Massicotte-Marquez J, Montplaisir J (2006) Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 66:845\u2013851","journal-title":"Neurology"},{"key":"9051_CR46","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1212\/WNL.0000000000001364","volume":"84","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Gagnon JF, Bertrand JA, Genier Marchand D, Montplaisir JY (2015) Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials. Neurology 84:1104\u20131113. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000001364","journal-title":"Neurology"},{"key":"9051_CR47","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","volume":"72","author":"SM Fereshtehnejad","year":"2015","unstructured":"Fereshtehnejad SM, Romenets SR, Anang JB, Latreille V, Gagnon JF, Postuma RB (2015) New clinical subtypes of parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol 72:863\u2013873. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2015.0703","journal-title":"JAMA Neurol"},{"key":"9051_CR48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-genom-082410-101440","volume":"12","author":"I Martin","year":"2011","unstructured":"Martin I, Dawson VL, Dawson TM (2011) Recent advances in the genetics of Parkinson\u2019s disease. Annu Rev Genom Hum Genet 12:301\u2013325. \n                    https:\/\/doi.org\/10.1146\/annurev-genom-082410-101440","journal-title":"Annu Rev Genom Hum Genet"},{"key":"9051_CR49","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1212\/WNL.0b013e318227042d","volume":"77","author":"C Marras","year":"2011","unstructured":"Marras C, Schule B, Munhoz RP, Rogaeva E, Langston JW, Kasten M, Meaney C, Klein C, Wadia PM, Lim SY, Chuang RS, Zadikof C, Steeves T, Prakash KM, de Bie RM, Adeli G, Thomsen T, Johansen KK, Teive HA, Asante A, Reginold W, Lang AE (2011) Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology 77:325\u2013333. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e318227042d","journal-title":"Neurology"},{"key":"9051_CR50","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1212\/WNL.42.4.887","volume":"42","author":"MJ Price","year":"1992","unstructured":"Price MJ, Feldman RG, Adelberg D, Kayne H (1992) Abnormalities in color vision and contrast sensitivity in Parkinson\u2019s disease. Neurology 42:887\u2013890","journal-title":"Neurology"},{"key":"9051_CR51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/BF02252659","volume":"7","author":"T Buttner","year":"1994","unstructured":"Buttner T, Kuhn W, Patzold T, Przuntek H (1994) L-Dopa improves colour vision in Parkinson\u2019s disease. J Neural Transm Park Dis Dement Sect 7:13\u201319","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"9051_CR52","doi-asserted-by":"publisher","first-page":"5696","DOI":"10.1167\/iovs.16-20025","volume":"57","author":"W Ming","year":"2016","unstructured":"Ming W, Palidis DJ, Spering M, McKeown MJ (2016) Visual Contrast Sensitivity in Early-Stage Parkinson\u2019s Disease. Invest Ophthalmol Vis Sci 57:5696\u20135704. \n                    https:\/\/doi.org\/10.1167\/iovs.16-20025","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9051_CR53","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1136\/bjo.68.12.885","volume":"68","author":"D Regan","year":"1984","unstructured":"Regan D, Neima D (1984) Low-contrast letter charts in early diabetic retinopathy, ocular hypertension, glaucoma, and Parkinson\u2019s disease. Br J Ophthalmol 68:885\u2013889","journal-title":"Br J Ophthalmol"},{"issue":"Pt 6","key":"9051_CR54","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/brain\/110.6.1675","volume":"110","author":"I Bodis-Wollner","year":"1987","unstructured":"Bodis-Wollner I, Marx MS, Mitra S, Bobak P, Mylin L, Yahr M (1987) Visual dysfunction in Parkinson\u2019s disease. Loss in spatiotemporal contrast sensitivity. Brain 110(Pt 6):1675\u20131698","journal-title":"Brain"},{"key":"9051_CR55","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1212\/WNL.40.11.1710","volume":"40","author":"D Mestre","year":"1990","unstructured":"Mestre D, Blin O, Serratrice G, Pailhous J (1990) Spatiotemporal contrast sensitivity differs in normal aging and Parkinson\u2019s disease. Neurology 40:1710\u20131714","journal-title":"Neurology"},{"key":"9051_CR56","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1212\/WNL.41.8.1200","volume":"41","author":"JT Hutton","year":"1991","unstructured":"Hutton JT, Morris JL, Elias JW, Varma R, Poston JN (1991) Spatial contrast sensitivity is reduced in bilateral Parkinson\u2019s disease. Neurology 41:1200\u20131202","journal-title":"Neurology"},{"key":"9051_CR57","first-page":"323","volume":"45","author":"I Bodis-Wollner","year":"1987","unstructured":"Bodis-Wollner I, Onofrj M (1987) The visual system in Parkinson\u2019s disease. Adv Neurol 45:323\u2013327","journal-title":"Adv Neurol"},{"key":"9051_CR58","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/ana.410220313","volume":"22","author":"C Bulens","year":"1987","unstructured":"Bulens C, Meerwaldt JD, Van der Wildt GJ, Van Deursen JB (1987) Effect of levodopa treatment on contrast sensitivity in Parkinson\u2019s disease. Ann Neurol 22:365\u2013369. \n                    https:\/\/doi.org\/10.1002\/ana.410220313","journal-title":"Ann Neurol"},{"key":"9051_CR59","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/archneur.1993.00540070041012","volume":"50","author":"JT Hutton","year":"1993","unstructured":"Hutton JT, Morris JL, Elias JW (1993) Levodopa improves spatial contrast sensitivity in Parkinson\u2019s disease. Arch Neurol 50:721\u2013724","journal-title":"Arch Neurol"},{"key":"9051_CR60","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.parkreldis.2009.01.002","volume":"15","author":"T Blekher","year":"2009","unstructured":"Blekher T, Weaver M, Rupp J, Nichols WC, Hui SL, Gray J, Yee RD, Wojcieszek J, Foroud T (2009) Multiple step pattern as a biomarker in Parkinson disease. Parkinsonism Relat Disord 15:506\u2013510. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2009.01.002","journal-title":"Parkinsonism Relat Disord"},{"key":"9051_CR61","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/archneur.1979.00500420070009","volume":"36","author":"H Shibasaki","year":"1979","unstructured":"Shibasaki H, Tsuji S, Kuroiwa Y (1979) Oculomotor abnormalities in Parkinson\u2019s disease. Arch Neurol 36:360\u2013364","journal-title":"Arch Neurol"},{"key":"9051_CR62","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.clinph.2013.01.021","volume":"124","author":"Y Terao","year":"2013","unstructured":"Terao Y, Fukuda H, Ugawa Y, Hikosaka O (2013) New perspectives on the pathophysiology of Parkinson\u2019s disease as assessed by saccade performance: a clinical review. Clin Neurophysiol 124:1491\u20131506. \n                    https:\/\/doi.org\/10.1016\/j.clinph.2013.01.021","journal-title":"Clin Neurophysiol"},{"key":"9051_CR63","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/0014-4886(71)90165-8","volume":"32","author":"JD DeJong","year":"1971","unstructured":"DeJong JD, Jones GM (1971) Akinesia, hypokinesia, and bradykinesia in the oculomotor system of patients with Parkinson\u2019s disease. Exp Neurol 32:58\u201368","journal-title":"Exp Neurol"},{"key":"9051_CR64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0014-4886(71)90173-7","volume":"31","author":"GM Jones","year":"1971","unstructured":"Jones GM, DeJong JD (1971) Dynamic characteristics of saccadic eye movements in Parkinson\u2019s disease. Exp Neurol 31:17\u201331","journal-title":"Exp Neurol"},{"key":"9051_CR65","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1136\/jnnp.52.9.1033","volume":"52","author":"T Crawford","year":"1989","unstructured":"Crawford T, Goodrich S, Henderson L, Kennard C (1989) Predictive responses in Parkinson\u2019s disease: manual keypresses and saccadic eye movements to regular stimulus events. J Neurol Neurosurg Psychiatry 52:1033\u20131042","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 3","key":"9051_CR66","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/brain\/106.3.571","volume":"106","author":"OB White","year":"1983","unstructured":"White OB, Saint-Cyr JA, Tomlinson RD, Sharpe JA (1983) Ocular motor deficits in Parkinson\u2019s disease. II. Control of the saccadic and smooth pursuit systems. Brain 106(Pt 3):571\u2013587","journal-title":"Brain"},{"key":"9051_CR67","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4103\/0301-4738.133482","volume":"62","author":"A Srivastava","year":"2014","unstructured":"Srivastava A, Sharma R, Sood SK, Shukla G, Goyal V, Behari M (2014) Saccadic eye movements in Parkinson\u2019s disease. Indian J Ophthalmol 62:538\u2013544. \n                    https:\/\/doi.org\/10.4103\/0301-4738.133482","journal-title":"Indian J Ophthalmol"},{"key":"9051_CR68","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.neuropsychologia.2011.03.002","volume":"49","author":"Y Terao","year":"2011","unstructured":"Terao Y, Fukuda H, Yugeta A, Hikosaka O, Nomura Y, Segawa M, Hanajima R, Tsuji S, Ugawa Y (2011) Initiation and inhibitory control of saccades with the progression of Parkinson\u2019s disease\u2014changes in three major drives converging on the superior colliculus. Neuropsychologia 49:1794\u20131806. \n                    https:\/\/doi.org\/10.1016\/j.neuropsychologia.2011.03.002","journal-title":"Neuropsychologia"},{"key":"9051_CR69","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1046\/j.1460-9568.2003.02570.x","volume":"17","author":"B Gaymard","year":"2003","unstructured":"Gaymard B, Lynch J, Ploner CJ, Condy C, Rivaud-Pechoux S (2003) The parieto-collicular pathway: anatomical location and contribution to saccade generation. Eur J Neurosci 17:1518\u20131526","journal-title":"Eur J Neurosci"},{"key":"9051_CR70","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/jnnp.53.4.284","volume":"53","author":"CJ Lueck","year":"1990","unstructured":"Lueck CJ, Tanyeri S, Crawford TJ, Henderson L, Kennard C (1990) Antisaccades and remembered saccades in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 53:284\u2013288","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9051_CR71","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s002210050934","volume":"129","author":"KA Briand","year":"1999","unstructured":"Briand KA, Strallow D, Hening W, Poizner H, Sereno AB (1999) Control of voluntary and reflexive saccades in Parkinson\u2019s disease. Exp Brain Res 129:38\u201348","journal-title":"Exp Brain Res"},{"key":"9051_CR72","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.neuropsychologia.2004.06.026","volume":"43","author":"F Chan","year":"2005","unstructured":"Chan F, Armstrong IT, Pari G, Riopelle RJ, Munoz DP (2005) Deficits in saccadic eye-movement control in Parkinson\u2019s disease. Neuropsychologia 43:784\u2013796. \n                    https:\/\/doi.org\/10.1016\/j.neuropsychologia.2004.06.026","journal-title":"Neuropsychologia"},{"key":"9051_CR73","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3109\/00016488709107331","volume":"104","author":"DH Zackon","year":"1987","unstructured":"Zackon DH, Sharpe JA (1987) Smooth pursuit in senescence. Effects of target acceleration and velocity. Acta Otolaryngol 104:290\u2013297","journal-title":"Acta Otolaryngol"},{"key":"9051_CR74","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1136\/jnnp.50.7.853","volume":"50","author":"JM Gibson","year":"1987","unstructured":"Gibson JM, Pimlott R, Kennard C (1987) Ocular motor and manual tracking in Parkinson\u2019s disease and the effect of treatment. J Neurol Neurosurg Psychiatry 50:853\u2013860","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9051_CR75","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1460-9568.2005.04215.x","volume":"22","author":"MA Basso","year":"2005","unstructured":"Basso MA, Pokorny JJ, Liu P (2005) Activity of substantia nigra pars reticulata neurons during smooth pursuit eye movements in monkeys. Eur J Neurosci 22:448\u2013464. \n                    https:\/\/doi.org\/10.1111\/j.1460-9568.2005.04215.x","journal-title":"Eur J Neurosci"},{"key":"9051_CR76","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S1353-8020(02)00015-9","volume":"9","author":"M Bares","year":"2003","unstructured":"Bares M, Brazdil M, Kanovsky P, Jurak P, Daniel P, Kukleta M, Rektor I (2003) The effect of apomorphine administration on smooth pursuit ocular movements in early Parkinsonian patients. Parkinsonism Relat Disord 9:139\u2013144","journal-title":"Parkinsonism Relat Disord"},{"key":"9051_CR77","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/ana.410390611","volume":"39","author":"JA Waterston","year":"1996","unstructured":"Waterston JA, Barnes GR, Grealy MA, Collins S (1996) Abnormalities of smooth eye and head movement control in Parkinson\u2019s disease. Ann Neurol 39:749\u2013760. \n                    https:\/\/doi.org\/10.1002\/ana.410390611","journal-title":"Ann Neurol"},{"key":"9051_CR78","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1136\/jnnp.54.7.599","volume":"54","author":"O Rascol","year":"1991","unstructured":"Rascol O, Sabatini U, Simonetta-Moreau M, Montastruc JL, Rascol A, Clanet M (1991) Square wave jerks in parkinsonian syndromes. J Neurol Neurosurg Psychiatry 54:599\u2013602","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9051_CR79","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1016\/j.visres.2004.05.009","volume":"44","author":"RV Abadi","year":"2004","unstructured":"Abadi RV, Gowen E (2004) Characteristics of saccadic intrusions. Vision Res 44:2675\u20132690. \n                    https:\/\/doi.org\/10.1016\/j.visres.2004.05.009","journal-title":"Vision Res"},{"key":"9051_CR80","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/bjo.2010.179630","volume":"95","author":"AG Shaikh","year":"2011","unstructured":"Shaikh AG, Xu-Wilson M, Grill S, Zee DS (2011) \u2018Staircase\u2019 square-wave jerks in early Parkinson\u2019s disease. Br J Ophthalmol 95:705\u2013709. \n                    https:\/\/doi.org\/10.1136\/bjo.2010.179630","journal-title":"Br J Ophthalmol"},{"key":"9051_CR81","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1212\/WNL.52.1.185","volume":"52","author":"L Averbuch-Heller","year":"1999","unstructured":"Averbuch-Heller L, Stahl JS, Hlavin ML, Leigh RJ (1999) Square-wave jerks induced by pallidotomy in parkinsonian patients. Neurology 52:185\u2013188","journal-title":"Neurology"},{"key":"9051_CR82","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.ophtha.2014.12.010","volume":"122","author":"R Ghadban","year":"2015","unstructured":"Ghadban R, Martinez JM, Diehl NN, Mohney BG (2015) The incidence and clinical characteristics of adult-onset convergence insufficiency. Ophthalmology 122:1056\u20131059. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2014.12.010","journal-title":"Ophthalmology"},{"key":"9051_CR83","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1076\/stra.7.3.169.636","volume":"7","author":"BA Racette","year":"1999","unstructured":"Racette BA, Gokden MS, Tychsen LS, Perlmutter JS (1999) Convergence insufficiency in idiopathic Parkinson\u2019s disease responsive to levodopa. Strabismus 7:169\u2013174","journal-title":"Strabismus"},{"key":"9051_CR84","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.12659\/MSM.890861","volume":"20","author":"B Nowacka","year":"2014","unstructured":"Nowacka B, Lubinski W, Honczarenko K, Potemkowski A, Safranow K (2014) Ophthalmological features of Parkinson disease. Med Sci Monit 20:2243\u20132249. \n                    https:\/\/doi.org\/10.12659\/MSM.890861","journal-title":"Med Sci Monit"},{"key":"9051_CR85","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ophtha.2011.06.040","volume":"119","author":"Z Almer","year":"2012","unstructured":"Almer Z, Klein KS, Marsh L, Gerstenhaber M, Repka MX (2012) Ocular motor and sensory function in Parkinson\u2019s disease. Ophthalmology 119:178\u2013182. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2011.06.040","journal-title":"Ophthalmology"},{"key":"9051_CR86","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1001\/archneurol.2012.70","volume":"69","author":"GT Gitchel","year":"2012","unstructured":"Gitchel GT, Wetzel PA, Baron MS (2012) Pervasive ocular tremor in patients with Parkinson disease. Arch Neurol 69:1011\u20131017. \n                    https:\/\/doi.org\/10.1001\/archneurol.2012.70","journal-title":"Arch Neurol"},{"key":"9051_CR87","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/mds.25514","volume":"28","author":"C Duval","year":"2013","unstructured":"Duval C (2013) Ocular tremor in Parkinson\u2019s disease: the debate is not over. Mov Disord 28:713\u2013714. \n                    https:\/\/doi.org\/10.1002\/mds.25514","journal-title":"Mov Disord"},{"key":"9051_CR88","doi-asserted-by":"publisher","unstructured":"Gitchel GT, Wetzel PA, Baron MS (2013) Slowed saccades and increased square wave jerks in essential tremor. Tremor Other Hyperkinet Mov (N Y) 3. \n                    https:\/\/doi.org\/10.7916\/D8251GXN","DOI":"10.7916\/D8251GXN"},{"key":"9051_CR89","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/mds.25342","volume":"28","author":"D Kaski","year":"2013","unstructured":"Kaski D, Saifee TA, Buckwell D, Bronstein AM (2013) Ocular tremor in Parkinson\u2019s disease is due to head oscillation. Mov Disord 28:534\u2013537. \n                    https:\/\/doi.org\/10.1002\/mds.25342","journal-title":"Mov Disord"},{"key":"9051_CR90","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1017\/S0317167100011501","volume":"38","author":"SH Kim","year":"2011","unstructured":"Kim SH, Park JH, Kim YH, Koh SB (2011) Stereopsis in drug naive Parkinson\u2019s disease patients. Can J Neurol Sci 38:299\u2013302","journal-title":"Can J Neurol Sci"},{"key":"9051_CR91","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/2047-783X-19-29","volume":"19","author":"L Sun","year":"2014","unstructured":"Sun L, Zhang H, Gu Z, Cao M, Li D, Chan P (2014) Stereopsis impairment is associated with decreased color perception and worse motor performance in Parkinson\u2019s disease. Eur J Med Res 19:29. \n                    https:\/\/doi.org\/10.1186\/2047-783X-19-29","journal-title":"Eur J Med Res"},{"key":"9051_CR92","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1017\/cjn.2014.3","volume":"41","author":"KY Kwon","year":"2014","unstructured":"Kwon KY, Kang SH, Kim M, Lee HM, Jang JW, Kim JY, Lee SM, Koh SB (2014) Nonmotor symptoms and cognitive decline in de novo Parkinson\u2019s disease. Can J Neurol Sci 41:597\u2013602. \n                    https:\/\/doi.org\/10.1017\/cjn.2014.3","journal-title":"Can J Neurol Sci"},{"key":"9051_CR93","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrneurol.2009.62","volume":"5","author":"NJ Diederich","year":"2009","unstructured":"Diederich NJ, Fenelon G, Stebbins G, Goetz CG (2009) Hallucinations in Parkinson disease. Nat Rev Neurol 5:331\u2013342. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2009.62","journal-title":"Nat Rev Neurol"},{"key":"9051_CR94","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov Disord 23:837\u2013844. \n                    https:\/\/doi.org\/10.1002\/mds.21956","journal-title":"Mov Disord"},{"key":"9051_CR95","first-page":"115","volume":"65","author":"SA Factor","year":"1995","unstructured":"Factor SA, Molho ES, Podskalny GD, Brown D (1995) Parkinson\u2019s disease: drug-induced psychiatric states. Adv Neurol 65:115\u2013138","journal-title":"Adv Neurol"},{"key":"9051_CR96","first-page":"289","volume":"21","author":"NJ Diederich","year":"1998","unstructured":"Diederich NJ, Goetz CG, Raman R, Pappert EJ, Leurgans S, Piery V (1998) Poor visual discrimination and visual hallucinations in Parkinson\u2019s disease. Clin Neuropharmacol 21:289\u2013295","journal-title":"Clin Neuropharmacol"},{"key":"9051_CR97","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.26432","volume":"31","author":"J Pagonabarraga","year":"2016","unstructured":"Pagonabarraga J, Martinez-Horta S, Fernandez de Bobadilla R, Perez J, Ribosa-Nogue R, Marin J, Pascual-Sedano B, Garcia C, Gironell A, Kulisevsky J (2016) Minor hallucinations occur in drug-naive Parkinson\u2019s disease patients, even from the premotor phase. Mov Disord 31:45\u201352. \n                    https:\/\/doi.org\/10.1002\/mds.26432","journal-title":"Mov Disord"},{"key":"9051_CR98","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/archneurol.2010.166","volume":"67","author":"EB Forsaa","year":"2010","unstructured":"Forsaa EB, Larsen JP, Wentzel-Larsen T, Goetz CG, Stebbins GT, Aarsland D, Alves G (2010) A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol 67:996\u20131001. \n                    https:\/\/doi.org\/10.1001\/archneurol.2010.166","journal-title":"Arch Neurol"},{"key":"9051_CR99","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1212\/WNL.26.4.305","volume":"26","author":"RD Sweet","year":"1976","unstructured":"Sweet RD, McDowell FH, Feigenson JS, Loranger AW, Goodell H (1976) Mental symptoms in Parkinson\u2019s disease during chronic treatment with levodopa. Neurology 26:305\u2013310","journal-title":"Neurology"},{"key":"9051_CR100","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00702-004-0209-9","volume":"111","author":"D Merims","year":"2004","unstructured":"Merims D, Shabtai H, Korczyn AD, Peretz C, Weizman N, Giladi N (2004) Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson\u2019s disease. J Neural Transm 111:1447\u20131453. \n                    https:\/\/doi.org\/10.1007\/s00702-004-0209-9","journal-title":"J Neural Transm"},{"key":"9051_CR101","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrneurol.2016.200","volume":"13","author":"DH Ffytche","year":"2017","unstructured":"Ffytche DH, Creese B, Politis M, Chaudhuri KR, Weintraub D, Ballard C, Aarsland D (2017) The psychosis spectrum in Parkinson disease. Nat Rev Neurol 13:81\u201395. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2016.200","journal-title":"Nat Rev Neurol"},{"key":"9051_CR102","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1212\/WNL.0000000000000842","volume":"83","author":"JB Anang","year":"2014","unstructured":"Anang JB, Gagnon JF, Bertrand JA, Romenets SR, Latreille V, Panisset M, Montplaisir J, Postuma RB (2014) Predictors of dementia in Parkinson disease: a prospective cohort study. Neurology 83:1253\u20131260. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000000842","journal-title":"Neurology"},{"key":"9051_CR103","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1001\/archneur.59.8.1249","volume":"59","author":"NJ Diederich","year":"2002","unstructured":"Diederich NJ, Raman R, Leurgans S, Goetz CG (2002) Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. Arch Neurol 59:1249\u20131252","journal-title":"Arch Neurol"},{"key":"9051_CR104","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1212\/WNL.51.2.363","volume":"51","author":"BF Boeve","year":"1998","unstructured":"Boeve BF, Silber MH, Ferman TJ, Kokmen E, Smith GE, Ivnik RJ, Parisi JE, Olson EJ, Petersen RC (1998) REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease. Neurology 51:363\u2013370","journal-title":"Neurology"},{"key":"9051_CR105","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1016\/S0042-6989(97)00398-2","volume":"38","author":"J Birch","year":"1998","unstructured":"Birch J, Kolle RU, Kunkel M, Paulus W, Upadhyay P (1998) Acquired colour deficiency in patients with Parkinson\u2019s disease. Vision Res 38:3421\u20133426","journal-title":"Vision Res"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9051-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-9051-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9051-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T13:05:17Z","timestamp":1589634317000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-9051-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,12]]},"references-count":105,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["9051"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-9051-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,12]]},"assertion":[{"value":"9 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This manuscript is a review of past clinical studies, all of which were performed in accordance with ethical standards in effect on their respective publication dates.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval for research involving human participants"}},{"value":"All authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}